The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa

Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents

(2017) Łukasz Matusiak et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adalimumab: A Review in Hidradenitis Suppurativa

(2016) Esther S. Kim et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum

(2016) J.L. Blok et al.   BRITISH JOURNAL OF DERMATOLOGY

Inflammatory Mechanisms in Hidradenitis Suppurativa

(2016) G. Kelly et al.   DERMATOLOGIC CLINICS

IL-6 pathway in the liver: From physiopathology to therapy

(2016) Dirk Schmidt-Arras et al.   JOURNAL OF HEPATOLOGY

Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?

(2015) Ł Matusiak et al.   ACTA DERMATO-VENEREOLOGICA

Évaluation clinique de la sévérité de l’hidradénite suppurée – maladie de Verneuil

(2015) J. Revuz   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients

(2015) Peter Theut Riis et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa

(2015) A.L. Lima et al.   BRITISH JOURNAL OF DERMATOLOGY

Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa

(2015) G. Kelly et al.   BRITISH JOURNAL OF DERMATOLOGY

Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)

(2015) Schapoor Hessam et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Treatment of hidradenitis suppurativa with biologic medications

(2015) Robert A. Lee et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pathophysiology of hidradenitis suppurativa: An update

(2015) Errol Prens et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes

(2015) Hessel H. van der Zee et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa: the role of immune dysregulation

(2014) Genevieve Kelly et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Interleukin 17A: Toward a new understanding of psoriasis pathogenesis

(2014) Charles W. Lynde et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The prevalence of metabolic syndrome in patients with hidradenitis suppurativa

(2014) Daniel A. Gold et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity

(2014) Anne M.R. Schrader et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

(2013) Alexa B. Kimball et al.   ANNALS OF INTERNAL MEDICINE

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments

(2012) Hessel H. van der Zee et al.   EXPERIMENTAL DERMATOLOGY

Hidradenitis Suppurativa

(2012) Gregor B.E. Jemec   NEW ENGLAND JOURNAL OF MEDICINE

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway

(2011) Kyung-Ah Cho et al.   INTERNATIONAL IMMUNOLOGY

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa

(2011) Christoph Schlapbach et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?

(2011) Z Rezaieyazdi et al.   LUPUS

Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?

(2009) L Matusiak et al.   ACTA DERMATO-VENEREOLOGICA

Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging

(2009) Łukasz Matusiak et al.   BIOMARKERS

Hidradenitis suppurativa

(2009) J Revuz   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY